Devices and methods for molecular diagnostic testing

Inventors

Andreyev, BorisMoravick, Keith E.Ciopyk, BrianBriones, VictorLoney, GregoryDe La Zerda, AdamChing, JesusChu, StevenSwenson, DavidHuang, HelenKelly, Colin

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Assignees

Visby Medical Inc

Member
Visby Medical
Visby Medical

Visby Medical develops rapid at-home molecular diagnostic tests powered by polymerase chain reaction (PCR) technology, focusing on accessible, private, and accurate screening for sexually transmitted infections (STIs). The company offers the first FDA-authorized over-the-counter at-home PCR test for women’s sexual health and is expanding its diagnostics platform to address other infectious diseases for point-of-care and home use. Its technology enables results in approximately 30 minutes via a secure mobile app, with integrated telehealth services for positive results. Visby Medical emphasizes user privacy, scalable manufacturing, and partnerships to broaden access to high-quality diagnostics.

Publication Number

US-11273443-B2

Patent

Publication Date

2022-03-15

Expiration Date


Abstract

A hand-held molecular diagnostic test device includes a housing, an amplification (or PCR) module, and a detection module. The amplification module is configured to receive an input sample, and defines a reaction volume. The amplification module includes a heater such that the amplification module can perform a polymerase chain reaction (PCR) on the input sample. The detection module is configured to receive an output from the amplification module and a reagent formulated to produce a signal that indicates a presence of a target amplicon within the input sample. The amplification module and the detection module are integrated within the housing.

Core Innovation

The invention is a disposable handheld, single-use molecular diagnostic test device in which the sample input module, the amplification module, and the detection module are integrated within a housing. The device conveys a solution comprising a target nucleic acid from a sample input module to an amplification module, amplifies by polymerase chain reaction to produce a target amplicon, conveys the solution to a detection module, and detects the target amplicon in the solution. The amplifying and detecting steps do not use any external instrument, and the device is discarded after a single use.

The invention addresses performing nucleic acid amplification and detection in a molecular diagnostic test device without using any external instrument while maintaining specified diagnostic performance. The method provides detection of a target nucleic acid with a sensitivity of at least about 93 percent and a specificity of at least about 95 percent. The device is positioned for decentralized use and includes a stand-alone molecular diagnostic test device with a flow path adapted to receive a biological sample from an input module.

The integrated device architecture enables amplifying and detecting steps within a housing-contained flow path, and includes process steps that convey a biological sample into a flow path, amplify within the flow path to produce a target amplicon, and detect within the same flow path. The invention also covers a one-time detection method in which the molecular diagnostic test device performs, at most one time before the molecular diagnostic test device is discarded, process steps comprising conveying a solution comprising a target nucleic acid from a sample input module to an amplification module, amplifying by polymerase chain reaction to produce a target amplicon, conveying the solution to a detection module, and detecting the target amplicon in the solution.

Claims Coverage

The independent claims are directed to a stand-alone, single-use molecular diagnostic test device and methods for detecting a target nucleic acid by conveying sample to internal modules for polymerase chain reaction amplification and detection within the same housing and flow path without external instrumentation, with sensitivity and specificity thresholds. Across the independent claims, the main inventive features are integrated module workflow, stand-alone operation at a decentralized location, single-use or at-most-one processing, and claimed sensitivity and specificity thresholds.

Integrated sample input, amplification, and detection modules in a housing

The sample input module, the amplification module, and the detection module are integrated within a housing while conveying a solution comprising a target nucleic acid from the sample input module to the amplification module, conveying the solution to the detection module, and detecting a target amplicon in the solution.

No external instrument for amplifying and detecting

The molecular diagnostic test device does not use any external instrument to perform the amplifying and detecting steps, including amplifying by polymerase chain reaction to produce a target amplicon and then detecting the target amplicon.

Single-use disposal of the molecular diagnostic test device

The molecular diagnostic test device is discarded after a single use.

Sensitivity and specificity performance thresholds

The method has a sensitivity of at least about 93 percent and a specificity of at least about 95 percent for the detection of the target nucleic acid.

Stand-alone molecular diagnostic test device at a decentralized location

Providing at a decentralized location a molecular diagnostic test device comprising a flow path adapted to receive a biological sample from an input module, the molecular diagnostic test device being a stand-alone molecular diagnostic test device.

Same flow path amplification and detection within a housing-contained flow path

The amplifying step and the detecting step are performed within the same flow path contained within a housing.

At most one processing cycle before discarding

The molecular diagnostic test device performs, at most one time before the molecular diagnostic test device is discarded, process steps comprising: conveying a solution comprising a target nucleic acid from a sample input module to an amplification module; amplifying by polymerase chain reaction the target nucleic acid to produce a target amplicon in the solution; conveying the solution to a detection module; and detecting the target amplicon in the solution.

Across the independent claims, the inventive coverage centers on a stand-alone, single-use molecular diagnostic test device with integrated sample input, PCR amplification, and detection modules within a housing, performing amplifying and detecting without any external instrument, and achieving sensitivity at least about 93 percent and specificity at least about 95 percent for detecting the target nucleic acid.

Stated Advantages

Provides a stand-alone molecular diagnostic test device that does not use any external instrument to perform amplifying and detecting steps.

Provides diagnostic performance with sensitivity of at least about 93 percent and specificity of at least about 95 percent for the detection of the target nucleic acid.

Enables single-use disposal of the molecular diagnostic test device after a single use or after at most one processing cycle.

Documented Applications

Nucleic acid testing for detecting a target nucleic acid at a decentralized location using a stand-alone molecular diagnostic test device.

Decentralized location nucleic acid testing using a stand-alone molecular diagnostic test device that performs polymerase chain reaction amplification and detection within the same flow path in a housing.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.